MEDICA & SFTS

IBJB targets the global stage with its presence at MEDICA and renews its commitment to the French Society of Blood Transfusion (SFTS)

In 2025, the Institut de Biotechnologies Jacques Boy (IBJB) is taking a key step in its international development. We are proud to announce our very first participation in the MEDICA trade fair in Düsseldorf, one of the largest global events in the medical sector. In parallel, we are reaffirming our long-standing commitment to the Francophone blood transfusion community at the SFTS congress in Brussels.

MEDICA: 17–20 November 2025 (Stand Hall 1 / B71): A global debut to showcase French innovation

Our presence at the MEDICA trade fair marks our entry onto the largest global stage for health technologies. This strategic event is the opportunity to present the excellence of our expertise, a legacy of French research and production, to an international audience.

It is an exceptional showcase for our cutting-edge innovations, notably our flagship product, the Free DNA Fetal Kit RhD-Duplex, the first Class D CE-IVD test compliant with Regulation (EU) 2017/746. We will demonstrate the reliability of our In Vitro Diagnostic Medical Devices (IVDMDs), all developed and manufactured in accordance with the ISO 13485:2016 standard and recognised by the Bpifrance Excellence distinction.

SFTS 2025: 11–12 December 2025 (Hall 2 / 4): The continuation of an expert partnership

While turning towards new horizons, we remain loyal to our long-standing partners. Our renewed presence at the SFTS congress is essential for continuing to engage with experts in this field.

This unmissable event will allow us to present, among other things, our solutions dedicated to performance and safety, thanks to our wide range of IQC (Internal Quality Control), thereby facilitating the accreditation of your laboratories in accordance with the ISO 15189:2012 standard.

This dual presence perfectly illustrates our vision: to elevate French innovation to the highest international level, while nurturing the relationship of trust and proximity that binds us to healthcare professionals.

Our team looks forward to meeting you in Düsseldorf and Brussels to build the future of in vitro diagnostics together.